Institutional investors purchased a net $3.3 million shares of NEO during the quarter ended December 2016, and now own 59.79% of the total float, a percentage that is typical for companies in the Medical/Nursing Services industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PRINCIPAL MANAGEMENT CORP. Bought 37.6 Thousand shares of Neogenomics Inc
VANGUARD INVESTMENTS AUSTRALIA L... Bought 3.4 Thousand shares of Neogenomics Inc
CREDIT SUISSE AG Bought 3.2 Thousand shares of Neogenomics Inc